The Manufacturers Life Insurance Company bought a new position in shares of Orthofix International N.V. (NASDAQ:OFIX) during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund bought 13,363 shares of the medical device company’s stock, valued at approximately $620,000. The Manufacturers Life Insurance Company owned 0.07% of Orthofix International N.V. as of its most recent SEC filing.
Other institutional investors also recently made changes to their positions in the company. Pinebridge Investments L.P. raised its position in shares of Orthofix International N.V. by 2.3% during the second quarter. Pinebridge Investments L.P. now owns 2,378 shares of the medical device company’s stock worth $111,000 after purchasing an additional 53 shares during the period. State of Alaska Department of Revenue raised its position in shares of Orthofix International N.V. by 79.3% during the second quarter. State of Alaska Department of Revenue now owns 3,551 shares of the medical device company’s stock worth $165,000 after purchasing an additional 1,571 shares during the period. Municipal Employees Retirement System of Michigan acquired a new stake in shares of Orthofix International N.V. during the second quarter worth $196,000. UBS Asset Management Americas Inc. acquired a new stake in shares of Orthofix International N.V. during the first quarter worth $229,000. Finally, New York State Teachers Retirement System acquired a new stake in shares of Orthofix International N.V. during the first quarter worth $262,000. 93.80% of the stock is currently owned by institutional investors.
A number of equities research analysts have recently issued reports on OFIX shares. TheStreet lowered Orthofix International N.V. from a “b” rating to a “c+” rating in a research report on Tuesday, October 31st. Zacks Investment Research lowered Orthofix International N.V. from a “buy” rating to a “hold” rating in a research report on Wednesday, November 8th. BidaskClub lowered Orthofix International N.V. from a “buy” rating to a “hold” rating in a research report on Tuesday, August 1st. BTIG Research set a $56.00 target price on Orthofix International N.V. and gave the stock a “buy” rating in a research report on Monday, October 30th. Finally, Jefferies Group LLC reaffirmed a “buy” rating and set a $55.00 target price (up from $50.00) on shares of Orthofix International N.V. in a research report on Thursday, August 10th. One equities research analyst has rated the stock with a hold rating and six have issued a buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and a consensus price target of $54.42.
TRADEMARK VIOLATION WARNING: This piece was originally reported by Sports Perspectives and is owned by of Sports Perspectives. If you are viewing this piece on another website, it was illegally stolen and reposted in violation of US & international trademark and copyright law. The correct version of this piece can be read at https://sportsperspectives.com/2017/11/21/the-manufacturers-life-insurance-company-takes-620000-position-in-orthofix-international-n-v-ofix.html.
Orthofix International N.V. (NASDAQ OFIX) opened at $53.29 on Tuesday. Orthofix International N.V. has a twelve month low of $32.51 and a twelve month high of $54.33. The firm has a market capitalization of $972.99, a price-to-earnings ratio of 34.88, a PEG ratio of 2.65 and a beta of 0.15.
Orthofix International N.V. (NASDAQ:OFIX) last issued its quarterly earnings results on Monday, October 30th. The medical device company reported $0.42 earnings per share for the quarter, beating analysts’ consensus estimates of $0.41 by $0.01. Orthofix International N.V. had a return on equity of 10.26% and a net margin of 0.33%. The business had revenue of $105.30 million for the quarter, compared to the consensus estimate of $100.67 million. During the same quarter in the previous year, the company posted $0.36 earnings per share. Orthofix International N.V.’s revenue for the quarter was up 6.9% compared to the same quarter last year. sell-side analysts expect that Orthofix International N.V. will post 1.61 earnings per share for the current fiscal year.
Orthofix International N.V. Company Profile
Orthofix International N.V. (Orthofix) is a global medical device company. The Company is focused on providing reconstructive and regenerative orthopedic and spine solutions to physicians. The company operates in four segments: BioStim, Biologics, Extremity Fixation and Spine Fixation. Its BioStim solutions products include Cervical-Stim, Spinal-Stim and Physio-Stim.
Want to see what other hedge funds are holding OFIX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Orthofix International N.V. (NASDAQ:OFIX).
Receive News & Ratings for Orthofix International N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orthofix International N.V. and related companies with MarketBeat.com's FREE daily email newsletter.